Nosocomial Bacterial and Fungal Chest Infections in Cirrhotic Patients

NCT03413293 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2018-05-18

No results posted yet for this study

Summary

Hospital acquired chest Infections are common complications in hospitalized cirrhotic patients. Infectious complications are the most common cause of mortality in cirrhotic patients with bronchopneumonia early antibiotic treatment at the base of culture and sensitivity is an optimal therapeutic approach in cirrhotics with nosocomial pneumonia Intensive care unit acquired pneumonia is the leading infection in critically ill patients and a major cause of morbidity and mortality despite recent major advances in antimicrobial therapy, supportive care, and the use of a broad range of preventive measures

Conditions

  • Nosocomial Infection

Interventions

DIAGNOSTIC_TEST

Diagnosis of bacterial infections

Cultures

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-30
Primary Completion
2019-05-31
Completion
2019-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03413293 on ClinicalTrials.gov